- Home
- ALVR vs OPOF Comparison
ALVR vs OPOF Comparison
Compare ALVR & OPOF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALVR
- OPOF
- Stock Information
- Founded
- ALVR 2013
- OPOF 1922
- Country
- ALVR United States
- OPOF United States
- Employees
- ALVR N/A
- OPOF N/A
- Industry
- ALVR Biotechnology: Biological Products (No Diagnostic Substances)
- OPOF Major Banks
- Sector
- ALVR Health Care
- OPOF Finance
- Exchange
- ALVR Nasdaq
- OPOF Nasdaq
- Market Cap
- ALVR 87.7M
- OPOF 103.7M
- IPO Year
- ALVR 2020
- OPOF N/A
- Fundamental
- Price
- ALVR $0.57
- OPOF $20.87
- Analyst Decision
- ALVR Sell
- OPOF
- Analyst Count
- ALVR 5
- OPOF 0
- Target Price
- ALVR $1.00
- OPOF N/A
- AVG Volume (30 Days)
- ALVR 593.0K
- OPOF 20.2K
- Earning Date
- ALVR 11-12-2024
- OPOF 10-24-2024
- Dividend Yield
- ALVR N/A
- OPOF 2.70%
- EPS Growth
- ALVR N/A
- OPOF N/A
- EPS
- ALVR N/A
- OPOF 1.60
- Revenue
- ALVR N/A
- OPOF $59,503,000.00
- Revenue This Year
- ALVR N/A
- OPOF N/A
- Revenue Next Year
- ALVR N/A
- OPOF N/A
- P/E Ratio
- ALVR N/A
- OPOF $12.73
- Revenue Growth
- ALVR N/A
- OPOF N/A
- 52 Week Low
- ALVR $0.52
- OPOF $13.49
- 52 Week High
- ALVR $2.49
- OPOF $21.89
- Technical
- Relative Strength Index (RSI)
- ALVR 37.63
- OPOF 59.82
- Support Level
- ALVR $0.52
- OPOF $20.30
- Resistance Level
- ALVR $0.64
- OPOF $21.89
- Average True Range (ATR)
- ALVR 0.10
- OPOF 0.66
- MACD
- ALVR -0.03
- OPOF -0.05
- Stochastic Oscillator
- ALVR 10.28
- OPOF 39.65
About ALVR AlloVir Inc.
AlloVir Inc is a late clinical-stage cell therapy company. The company focuses on developing innovative allogeneic T-cell therapies to combat viral diseases. Their proprietary VST therapy platform enables the creation of off-the-shelf VSTs, addressing the urgent medical need for treating patients with limited viral disease treatment options. With a singular focus on research, development, and commercialization, the company's platform targets 11 devastating viruses, with posoleucel being the lead candidate addressing six viruses. Operating within one segment, the company is dedicated to preventing and treating severe viral-associated diseases through off-the-shelf VST therapies.
About OPOF Old Point Financial Corporation
Old Point Financial Corp functions in the financial services domain in the United States. As the holding company of The Bank and Trust, it is a nationally chartered trust and wealth management service, provider. Its suite of services includes commercial banking solutions such as loan, deposit and cash management, which are rendered through a chain of branches throughout the country. It operates through segments such as Bank, Wealth and Company.